skip to main content

Chemistry, part 2

Content language

Contact us: CRM@email.irandoc.ac.ir

Concept information

organooxygen compound > oxacycle > oxazinane > morpholines > 2-[(2s,3s,6s)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2h-pyran-6-yl]-n-[3-(4-morpholinyl)propyl]acetamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > oxacycle > oxazinane > morpholines > 2-[(2s,3s,6s)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2h-pyran-6-yl]-n-[3-(4-morpholinyl)propyl]acetamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > oxazinane > morpholines > 2-[(2s,3s,6s)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2h-pyran-6-yl]-n-[3-(4-morpholinyl)propyl]acetamide
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > oxazinane > morpholines > 2-[(2s,3s,6s)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2h-pyran-6-yl]-n-[3-(4-morpholinyl)propyl]acetamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > oxazinane > morpholines > 2-[(2s,3s,6s)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2h-pyran-6-yl]-n-[3-(4-morpholinyl)propyl]acetamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > oxazinane > morpholines > 2-[(2s,3s,6s)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2h-pyran-6-yl]-n-[3-(4-morpholinyl)propyl]acetamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > oxazinane > morpholines > 2-[(2s,3s,6s)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2h-pyran-6-yl]-n-[3-(4-morpholinyl)propyl]acetamide
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > oxazinane > morpholines > 2-[(2s,3s,6s)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2h-pyran-6-yl]-n-[3-(4-morpholinyl)propyl]acetamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > oxazinane > morpholines > 2-[(2s,3s,6s)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2h-pyran-6-yl]-n-[3-(4-morpholinyl)propyl]acetamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > oxazinane > morpholines > 2-[(2s,3s,6s)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2h-pyran-6-yl]-n-[3-(4-morpholinyl)propyl]acetamide
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > oxazinane > morpholines > 2-[(2s,3s,6s)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2h-pyran-6-yl]-n-[3-(4-morpholinyl)propyl]acetamide

Preferred term

2-[(2s,3s,6s)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2h-pyran-6-yl]-n-[3-(4-morpholinyl)propyl]acetamide  

Type

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

Broader concept

charge

  • 0

formula

  • C22H32N4O5

inchi

  • InChI=1S/C22H32N4O5/c27-16-20-19(25-22(29)14-17-4-1-2-7-23-17)6-5-18(31-20)15-21(28)24-8-3-9-26-10-12-30-13-11-26/h1-2,4-7,18-20,27H,3,8-16H2,(H,24,28)(H,25,29)/t18-,19+,20-/m1/s1

inchikey

  • JNAWISBSOJGFKT-HSALFYBXSA-N

mass

  • 432.514

monoisotopicmass

  • 432.23727

smiles

  • C1COCCN1CCCNC(=O)C[C@H]2C=C[C@@H]([C@H](O2)CO)NC(=O)CC3=CC=CC=N3

subset

  • 2_STAR

In other languages

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:122475

Download this concept:

RDF/XML TURTLE JSON-LD